http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2007023775-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
| filingDate | 2006-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2007023775-A1 |
| titleOfInvention | Atrial fibrillation treatment |
| abstract | It is an object of the present invention to provide a therapeutic agent for atrial fibrillation containing an If current inhibitor as an active ingredient. The solution of the present invention relates to a therapeutic agent for atrial fibrillation containing an If current inhibitor as an active ingredient. Especially (-)-N- {2-[(R) -3- (6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl) piperidino] ethyl} -4-fluorobenzamide monophosphorus A therapeutic agent for atrial fibrillation containing an acid as an active ingredient is used as a solution. The active ingredient of the present invention has more suitable properties as a therapeutic agent for atrial fibrillation than the Ca antagonist verapamil and β-blocker atenolol which are conventionally used as a therapeutic agent for atrial fibrillation. |
| priorityDate | 2005-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.